AVR 2.32% $12.20 anteris technologies ltd

I suspect it'll have something to do with the ArcoMed devices...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 904 Posts.
    lightbulb Created with Sketch. 119
    I suspect it'll have something to do with the ArcoMed devices (AHZ infusion-device supplier) to the RAH, expect a bit of a bumpy-ride..!! Let's hope the 'transition' to majority 'ADAPT revenue-streams' can be somewhat accelerated...

    "...On the infusion side, Admedus’ fortunes were boosted with a recent contract to supply Arcomed infusion pumps to the Royal Adelaide Hospital, which threw open its doors to the ailing masses last September.
    Infusion is a significant part of the business: of Admedus’ revenue in 2016-2017, $15.5 million derives from infusion and $6.9 million from Adapt..."


    Source

    AHZ.jpg

    ML
    Last edited by morgenlofting: 06/06/18
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.